- CEO
- Kwon-Sun Lee
- Full Time Employees
- 97
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Anyang-si South Korea
- IPO Date
- Apr 20, 2023
- Business
- Cell Bio Human Tech Co., Ltd. is a South Korea-based biomaterials and cosmetics manufacturing company specializing in the development, production, and supply of high-performance cellulose nonwoven fabrics, functional skincare sheets, and cosmetic original development manufacturing (ODM) and original equipment manufacturing (OEM) solutions. Founded in July 2015 and headquartered in Anyang-si, Gyeonggi-do, South Korea, the company operates across the personal care, functional skincare, and bio-medical healthcare sectors.
The company's core business is organized into functional bio-materials, cosmetic finished goods manufacturing, and specialized healthcare patches. Its product and service portfolio comprises: proprietary cellulose nonwoven fabrics for facial sheet masks, including PT CELL (Premium Transparent Cell) bio-cellulose sheets characterized by high essence absorption and skin adhesion; SEMI GEL functional fabrics that convert into a gel structure upon moisture absorption; NF CELL, S CELL, and S BR customized functional fabric lines; cosmetic ODM and OEM services providing end-to-end skincare development, formulation, and packaging for sheet masks, toner pads, essence treatments, and nose strips; hydrocolloid-based personal care items, including acne spot patches, soothing facial blemish patches, and pore care pads; medical-grade wound care materials, including hydrocolloid wound dressings and protective skin barriers; and proprietary clean beauty skincare lines under brand names such as Lusom. The company caters to domestic and global cosmetics brand owners, contract manufacturers, and beauty distributors across key markets, including South Korea, China, Japan, the United States, and Europe.
Cell Bio Human Tech Co., Ltd. maintains corporate headquarters and manufacturing facilities in Anyang-si and Hwaseong-si, South Korea, and supports global distribution through its overseas manufacturing subsidiary, Staami Vina Co., Ltd. (Cellbiohumantech Vina), located in Vietnam. In recent corporate developments, the company listed its shares on the KOSDAQ market (Ticker: KRX:318160) through a merger with Daishin Balance No. 12 SPAC. To enhance its functional skincare offerings and research capabilities, the company formed a strategic partnership with Kolmar Korea Co., Ltd. to co-develop eco-friendly and high-functional cosmetic fiber materials. Furthermore, the company has expanded production processes at its Vietnam manufacturing facility to enhance cost efficiencies and scale global supply capacity, while executing a strategic business diversification from raw sheet mask materials into full-service finished skincare ODM, transdermal hydrocolloid patches, and medical wound dressings.